StonvexLoading…
StonvexStonvexStonvexCore line items from NDAQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.14B | $8.26B | $6.14B | $4.18B |
Operating Income | $657.00M | $2.33B | $1.70B | $1.11B |
Net Income | $519.00M | $1.79B | $1.27B | $847.00M |
EPS (Diluted) | $0.91 | $3.09 | $2.19 | $1.46 |
Total Assets | $27.30B | $31.05B | $30.65B | $30.38B |
Total Liabilities | $15.26B | $18.82B | $18.62B | $18.57B |
Cash & Equivalents | $515.00M | $604.00M | $470.00M | $732.00M |
Free Cash Flow OCF − CapEx | $629.00M | $1.99B | $1.45B | $1.30B |
Shares Outstanding | 564.75M | 569.89M | 572.75M | 573.91M |